<DOC>
	<DOCNO>NCT00154141</DOCNO>
	<brief_summary>A comparison fibrin sealant versus manual compression stop surgical bleeding vascular procedure .</brief_summary>
	<brief_title>Evaluation Fibrin Sealant 2 Vascular Surgical Procedures</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Male female subject , 18 year old , require elective , primary repeat vascular procedure least one endtoside femoral upper extremity vascular access arterial anastomosis ( e.g . femoralfemoral , femoralpopliteal , femoraltibial , iliofemoral , aortobifemoral , abdominal aortic aneurysm , upper extremity vascular access dialysis ) use uncoated heparincoated PTFE graft polypropylene suture ( size 50 60 ) 1:1 needletothread ratio . Following initial arterial clamp release , study surgeon determines adjunctive measure need obtain haemostasis SAS . Subjects must willing capable participating study , provide write informed consent . Subjects undergoing revascularisation use autologous conduit ( e.g . saphenous vein ) prosthetic material uncoated heparincoated PTFE . Subjects undergoing emergency surgery . Subjects intraoperative finding may preclude conduct study procedure . Subjects know intolerance heparin , blood product one component study product . Subjects unwilling receive blood product . Subjects autoimmune immunodeficiency disease ( include know HIV ) . Subjects know , current alcohol / drug abuser . Subjects participate another investigational drug device research study within 30 day enrolment . Female subject pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>